West Pharmaceutical Services, who provide innovative solutions for injectable drug administration, announced it has appointed Alessandra Rispoli to serve as Senior Director of Operations.
West has an unmatched global footprint, serving customers from its headquarters in Exton, Pennsylvania and more than 50 locations around the world.
Don O’Callaghan, Vice President of Global Operations at West EU, said: “We are delighted that Alessandra will be joining our team. She brings a breadth of expertise across all manufacturing disciplines and we look forward to her contributions.”
Rispoli will oversee the operations for West’s manufacturing site in Eschweiler, Germany.
West’s Eschweiler, Germany manufacturing plant produces components used in the primary packaging of injectable medicines manufactured by pharmaceutical and biotechnology customers throughout the world.
Rispoli has more than 20 years of experience in the pharmaceutical industry, including more than 12 years in manufacturing. She joins West from Biotest AG, where she served as Senior Director of Manufacturing Plasma Derived Proteins and was a member of the Biotest leadership team.
Prior to Biotest AG, Rispoli spent more than 14 years at Sanofi Germany in management roles in the Technology, Manufacturing and Innovation businesses.
Rispoli said: “I am excited to join West and become part of a company that is a leading global manufacturer and supplier to the world’s top pharmaceutical companies. I look forward to working with the team at Eschweiler, and will be proud to serve as the leader of one of West’s largest manufacturing sites and be a part of the Global Operations team.”
Rispoli holds a degree in Biology from the University of L’Aquila in Italy, a doctorate from the University of Medicine L’Aquila, and a Master’s in Business Administration in International Management and International Leadership from University Accadis in Germany. She also studied at the Massachusetts General Hospital/Harvard Medical School Cutaneous Biology Research Center.
